ROLE OF THE ADENYLATE-CYCLASE, PHOSPHOINOSITIDASE-C AND RECEPTOR TYROSYL KINASE SYSTEMS IN THE CONTROL OF HEPATOCYTE PROLIFERATION BY HEPATOCYTE GROWTH-FACTOR

被引:22
作者
MARKER, AJ
GALLOWAY, E
PALMER, S
NAKAMURA, T
GOULD, GW
MACSWEEN, RNM
BUSHFIELD, M
机构
[1] UNIV GLASGOW,DEPT PATHOL,GLASGOW G12 8QQ,SCOTLAND
[2] UNIV GLASGOW,DEPT BIOCHEM,GLASGOW G12 8QQ,SCOTLAND
[3] UNIV STRATHCLYDE,DEPT PHYSIOL & PHARMACOL,GLASGOW G1 1XW,SCOTLAND
[4] KYUSHU UNIV,DEPT BIOL,FUKUOKA 812,JAPAN
关键词
D O I
10.1016/0006-2952(92)90365-P
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hepatocyte growth factor (HGF) is the most potent known mitogen for hepatocytes in primary culture, However, the mechanisms through which HGF induces hepatocyte proliferation have not been defined. Here we have investigated the role of the adenylate cyclase, phosphoinositidase C and tyrosine kinase signalling systems in the control of hepatocyte proliferation by HGF using freshly isolated or cultured adult rat hepatocytes. We show that human recombinant HGF caused a dose-dependent increase in hepatocyte DNA synthesis with a maximal effect at 10 ng/mL and an EC50 Of 5.9 ng/mL. HGF had no effect on hepatocyte adenylate cyclase activity or intracellular cAMP levels. Elevation of hepatocyte cAMP levels resulted in inhibition of HGF-stimulated DNA synthesis. HGF stimulated inositol phospholipid hydrolysis with a maximal effect at 25 ng/mL and potentiated the effect of vasopressin (10(-8) and 10(-9) M). HGF (100 ng/mL) caused an increase in the phosphorylation on tyrosine of an unknown hepatocyte protein with a molecular mass of 36 kDa. Thus, we have shown that HGF, like epidermal growth factor (EGF), can activate the phosphoinositidase C and tyrosine kinase systems in rat hepatocytes. As with EGF, these intracellular signalling systems may underlie HGF-induced hepatocyte proliferation.
引用
收藏
页码:1037 / 1043
页数:7
相关论文
共 45 条
[1]   IDENTIFICATION OF THE HEPATOCYTE GROWTH-FACTOR RECEPTOR AS THE C-MET PROTOONCOGENE PRODUCT [J].
BOTTARO, DP ;
RUBIN, JS ;
FALETTO, DL ;
CHAN, AML ;
KMIECIK, TE ;
VANDEWOUDE, GF ;
AARONSON, SA .
SCIENCE, 1991, 251 (4995) :802-804
[2]   BIDIRECTIONAL CONCENTRATION-DEPENDENT EFFECTS OF GLUCAGON AND DIBUTYRYL-CYCLIC-AMP ON DNA-SYNTHESIS IN CULTURED ADULT-RAT HEPATOCYTES [J].
BRONSTAD, GO ;
SAND, TE ;
CHRISTOFFERSEN, T .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 763 (01) :58-63
[3]   HORMONAL-REGULATION OF GI2 ALPHA-SUBUNIT PHOSPHORYLATION IN INTACT HEPATOCYTES [J].
BUSHFIELD, M ;
MURPHY, GJ ;
LAVAN, BE ;
PARKER, PJ ;
HRUBY, VJ ;
MILLIGAN, G ;
HOUSLAY, MD .
BIOCHEMICAL JOURNAL, 1990, 268 (02) :449-457
[4]   ONCOGENES AND SIGNAL TRANSDUCTION [J].
CANTLEY, LC ;
AUGER, KR ;
CARPENTER, C ;
DUCKWORTH, B ;
GRAZIANI, A ;
KAPELLER, R ;
SOLTOFF, S .
CELL, 1991, 64 (02) :281-302
[5]  
FISHMAN JB, 1985, J BIOL CHEM, V260, P2641
[6]   LIGAND-INDUCED ENDOCYTOSIS OF THE EGF RECEPTOR IS BLOCKED BY MUTATIONAL INACTIVATION AND BY MICROINJECTION OF ANTI-PHOSPHOTYROSINE ANTIBODIES [J].
GLENNEY, JR ;
CHEN, WS ;
LAZAR, CS ;
WALTON, GM ;
ZOKAS, LM ;
ROSENFELD, MG ;
GILL, GN .
CELL, 1988, 52 (05) :675-684
[7]   BIOLOGICAL AND IMMUNOLOGICAL PROPERTIES OF HUMAN HEPATOCYTE GROWTH-FACTOR FROM PLASMA OF PATIENTS WITH FULMINANT HEPATIC-FAILURE [J].
GOHDA, E ;
YAMASAKI, T ;
TSUBOUCHI, H ;
KUROBE, M ;
SAKIYAMA, O ;
AOKI, H ;
NIIDANI, N ;
SHIN, S ;
HAYASHI, K ;
HASHIMOTO, S ;
DAIKUHARA, Y ;
YAMAMOTO, I .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1053 (01) :21-26
[8]   HUMAN HEPATOCYTE GROWTH-FACTOR IN PLASMA FROM PATIENTS WITH FULMINANT HEPATIC-FAILURE [J].
GOHDA, E ;
TSUBOUCHI, H ;
NAKAYAMA, H ;
HIRONO, S ;
TAKAHASHI, K ;
KOURA, M ;
HASHIMOTO, S ;
DAIKUHARA, Y .
EXPERIMENTAL CELL RESEARCH, 1986, 166 (01) :139-150
[9]   PURIFICATION AND PARTIAL CHARACTERIZATION OF HEPATOCYTE GROWTH-FACTOR FROM PLASMA OF A PATIENT WITH FULMINANT HEPATIC-FAILURE [J].
GOHDA, E ;
TSUBOUCHI, H ;
NAKAYAMA, H ;
HIRONO, S ;
SAKIYAMA, O ;
TAKAHASHI, K ;
MIYAZAKI, H ;
HASHIMOTO, S ;
DAIKUHARA, Y .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (02) :414-419
[10]  
GRAZIANI A, 1991, J BIOL CHEM, V266, P22087